Hypofractionated Tomotherapy with Concomitant Chemotherapy in Pancreatic Adenocarcinoma: Preliminary Results of a Phase I Study

被引：0
|
作者：
Slim, N. [1 ]
Cereda, S. [1 ]
Passoni, P. [1 ]
Reni, M. [1 ]
Cattaneo, M. [1 ]
Alongi, F. [1 ]
Sangalli, G. [1 ]
Bettinardi, V. [1 ]
Mancosu, P. [1 ]
Di Muzio, N. [1 ]
机构：
[1] Ist Sci San Raffaele, I-20132 Milan, Italy
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2009年 / 75卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2009.07.654
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S284 / S284
页数：1
相关论文
共 50 条
  • [31] PANOVA: A phase II study of TTFields (150kHz) concomitant with standard chemotherapy for front line therapy of advanced pancreatic adenocarcinoma
    Benavides, Manuel
    Guillen, Carmen
    Rivera, Fernando
    Gallego, Javier
    Lopez-Martin, Jose
    Kung, Marc
    CANCER RESEARCH, 2017, 77
  • [32] Chemotherapy of metastatic pancreatic adenocarcinoma: challenges and encouraging results
    Conroy, Thierry
    Mitry, Emmanuel
    BULLETIN DU CANCER, 2011, 98 (12) : 1439 - 1446
  • [33] PANOVA-2: A phase II study of TTFields (150 kHz) concomitant with standard chemotherapy for front-line therapy of advanced pancreatic adenocarcinoma - Updated efficacy results
    Manuel, Benavides
    Carmen, Guillen-Ponce
    Fernando, Rivera
    Javier, Gallego
    Jose, Lopez-Martin
    Marc, Kueng
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] PANOVA: A phase II study of TTFields (150 kHz) concomitant with standard chemotherapy for front-line therapy of advanced pancreatic adenocarcinoma-Updated efficacy results.
    Benavides, Manuel
    Guillen, Carmen
    Rivera, Fernando
    Gallego, Javier
    Lopez-Martin, Jose A.
    Kung, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] GEMCITABINE, OXALIPLATIN AND CAPECITABINE (GEMOXEL) FOR PATIENTS WITH ADVANCED PANCREATIC ADENOCARCINOMA (APC). PRELIMINARY RESULTS OF AN ONGOING PHASE I/II TRIAL
    Hess, V.
    Pestalozzi, B.
    Ludwig, C.
    Winterhalder, R.
    Lohri, A.
    Jost, L.
    Widmer, L.
    Lee, L.
    Stillhart, P.
    Herrmann, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 181 - 181
  • [36] Phase 1 study of hypofractionated radiation in combination with tremelimumab and durvalumab in refractory metastatic pancreatic adenocarcinoma.
    O'Hara, Mark H.
    Bear, Adham S.
    Wattenberg, Max M.
    Teitelbaum, Ursina R.
    Reiss, Kim A.
    Karasic, Thomas B.
    Schneider, Charles J.
    O'Dwyer, Peter J.
    Ben-Josef, Edgar H.
    Wojcieszynski, Andrzej P.
    Maity, Amit H.
    Mick, Rosemarie H.
    Vonderheide, Robert H.
    CANCER RESEARCH, 2022, 82 (22) : 8 - 9
  • [37] MIBEFRADIL DIHYDROCHORIDE WITH HYPOFRACTIONATED RADIATION FOR RECURRENT GLIOBLASTOMA: PRELIMINARY RESULTS OF A PHASE I DOSE EXPANSION TRIAL
    Lester-Coll, N. H.
    Kluytenaar, J.
    Pavlik, K. F.
    Piepmeier, J. M.
    Becker, K. P.
    Baehring, J. M.
    Huttner, A. J.
    Vortmeyer, A. O.
    Lampert, R. J.
    Bindra, R. S.
    Bindra, R. S.
    NEURO-ONCOLOGY, 2016, 18 : 51 - 51
  • [38] Safety and Efficacy Results of a Phase II Clinical Trial Evaluating Moderately- Hypofractionated Chemoradiotherapy for Pancreatic Ductal Adenocarcinoma
    Merrell, K. W.
    Hallemeier, C. L.
    Harmsen, W. S.
    Ashman, J. B.
    Truty, M.
    Leenstra, J. L.
    Timm, M. A.
    Owen, D.
    Thiels, C.
    Stucky, C. C. H.
    Wittich, M. Neben
    Bekaii-Saab, T.
    Rule, W. G.
    Garces, Y.
    McWilliams, R. R.
    Lester, S. C.
    Haddock, M. G.
    Sio, T. T. W.
    Jethwa, K. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S143 - S143
  • [39] Interim Results of a Phase I Risk-Stratified Dose Escalation Study using Hypofractionated Helical Tomotherapy for Non-small Cell Lung Cancer
    Cannon, D.
    Adkison, J. B.
    Chappell, R. J.
    Perumal, K.
    Khuntia, D.
    Tome, W. A.
    Bentzen, S. M.
    Cannon, G. M.
    Tolakanahalli, R.
    Mehta, M. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S107 - S108
  • [40] A phase I study of concomitant CPT-11 (C) and 5FU (F) combination: Preliminary results
    Rixe, O
    Benhammouda, A
    Farabos, C
    Borel, C
    Petit, T
    Auclerc, G
    Coeffic, D
    Bastian, G
    Grossin, F
    Paraiso, D
    Grapin, JP
    Nizri, D
    Weil, M
    Bismuth, H
    Mahjoubi, M
    Khayat, D
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 955 - 955
12345